Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory‐driven colon cancer. Issue 2 (9th December 2019)
- Record Type:
- Journal Article
- Title:
- Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory‐driven colon cancer. Issue 2 (9th December 2019)
- Main Title:
- Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory‐driven colon cancer
- Authors:
- Wu, Renyi
Wang, Lujing
Yin, Ran
Hudlikar, Rasika
Li, Shanyi
Kuo, Hsiao‐Chen D.
Peter, Rebecca
Sargsyan, Davit
Guo, Yue
Liu, Xia
Kong, AN - Abstract:
- Abstract: Colorectal cancer (CRC) is associated with significant morbidity and mortality in the US and worldwide. CRC is the second most common cancer‐related death in both men and women globally. Chronic inflammation has been identified as one of the major risk factors of CRC. It may drive genetic and epigenetic/epigenomic alterations, such as DNA methylation, histone modification, and non‐coding RNA regulation. Current prevention modalities for CRC are limited and some treatment regimens such as use the nonsteroidal anti‐inflammatory drug aspirin may have severe side effects, namely gastrointestinal ulceration and bleeding. Therefore, there is an urgent need of developing alternative strategies. Recently, increasing evidence suggests that several dietary cancer chemopreventive phytochemicals possess anti‐inflammation and antioxidative stress activities, and may prevent cancers including CRC. Curcumin (CUR) is the yellow pigment that is found in the rhizomes of turmeric ( Curcuma longa) . Many studies have demonstrated that CUR exhibit strong anticancer, antioxidative stress, and anti‐inflammatory activities by regulating signaling pathways, such as nuclear factor erythroid‐2‐related factor 2, nuclear factor‐κB, and epigenetics/epigenomics pathways of histones modifications, and DNA methylation. In this review, we will discuss the latest evidence in epigenetics/epigenomics alterations by CUR in CRC and their potential contribution in the prevention of CRC.
- Is Part Of:
- Molecular carcinogenesis. Volume 59:Issue 2(2020)
- Journal:
- Molecular carcinogenesis
- Issue:
- Volume 59:Issue 2(2020)
- Issue Display:
- Volume 59, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 59
- Issue:
- 2
- Issue Sort Value:
- 2020-0059-0002-0000
- Page Start:
- 227
- Page End:
- 236
- Publication Date:
- 2019-12-09
- Subjects:
- colon cancer -- curcumin -- epigenetics -- inflammation
Carcinogenesis -- Molecular aspects -- Periodicals
616.994071 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2744 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/mc.23146 ↗
- Languages:
- English
- ISSNs:
- 0899-1987
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.802000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12807.xml